The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Kimberly Noonan, PhD, MPH, WindMIL Therapeutics, Co-Founder and Executive Vice President, Chief Science & Technology Officer Kimberly Noonan, PhD, MPH, WindMIL Therapeutics, Co-Founder and Executive ...
BALTIMORE--(BUSINESS WIRE)--WindMIL Therapeutics, a clinical stage company developing Marrow-Infiltrating Lymphocytes (MILs™) for cancer immunotherapy, today announced the completion of a $32.5 ...
BALTIMORE and PHILADELPHIA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- WindMIL Therapeutics today announced it has entered into a new clinical research collaboration with Bristol-Myers Squibb Company (NYSE:BMY ...
PHILADELPHIA and BALTIMORE, April 21, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, today ...
TrakCel and WindMIL Therapeutics have formed a partnership to build a custom-configured cellular supply chain tracking and orchestration platform. TrakCel-a software developer for cell and gene ...
BALTIMORE and PHILADELPHIA, Feb. 05, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, today ...
PHILADELPHIA and BALTIMORE, Nov. 09, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocyte (MILs®) products for cancer immunotherapy, today ...
WildMil Therapeutics announced that cofounder Kimberly Noonan, Ph.D, MPH, has been named EVP, chief science and technology officer. “It’s an exciting time at WindMil, with the ongoing enrollment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results